![]() ![]() We express commitment to the diversity, inclusion and scientific collaboration among researchers interested in this emerging subdiscipline through expansion of the iVAMP consortium. We present an evidence-based argument for integrating microbiology as part of venomics (i.e., venom-microbiomics) and introduce iVAMP, the Initiative for Venom Associated Microbes and Parasites ( ), as a growing collaborative consortium. The considerable number of convergently evolved venomous animals, juxtaposed with the comparatively few known studies to identify microbial communities in venom, provides new possibilities for both biodiversity and therapeutic discoveries. We highlight the potential for the discovery of venom microbiomes within the adaptive landscape of venom systems. Venom-centric microbiome studies are relatively sparse to date with the adaptive advantages that venom-associated microbes might offer to their hosts, or that hosts might provide to venom-associated microbes, remaining largely unknown. Culture-dependent and -independent studies on the microbial communities in venom microenvironments reveal the presence of archaea, algae, bacteria, fungi, protozoa, and viruses. The substantial, increasing number of these discoveries have unintentionally culminated in the misconception that venom and venom-producing glands are largely sterile environments. Once logged in, you can download a printable resource to use in your back office and help your staff identify “vet shoppers” in an effort to combat drug diversion.Venom is a known source of novel antimicrobial natural products.Vet Shopping & Drug Diversion (AVMA login required).This link summarizes state laws and regulations defining veterinary continuing education requirements as it relates to specific provisions to opioids and/or other controlled substances.State-by-State CE Requirements (AVMA login required). ![]() This link summarizes state laws and regulations, showing the extent to which veterinarians are required to participate in prescription drug monitoring programs (PDMPs), including reporting requirements and database search requirements.State-by-State Prescription Drug Monitoring Program (AVMA login required).This policy outlines the objectives and efforts supported by the AVMA to address the national opioid epidemic.AVMA Policy: The Veterinary Profession’s Role in Addressing the Opioid Epidemic.What Veterinarians Need to Know About the Opioid Epidemic, By JAVMA News.Pain Relief Without Opioids? It’s Possible!, By Tamara Grubb, DVM, PhD, DACVAA.Why Doctors Don’t Use Alternatives to Opioids, By The Washington Post.Pfizer Suspends Delivery of Injectable Opioids to Veterinary Customers, By American Veterinarian.Simbadol (feline-specific buprenorphine).Remember, there are two opioids developed specific for veterinary use: Opioid-Sparing Pain Therapy in Animals: Working Task Force.Opioid-Sparing Task Force releases White Paper for review – click below to read and learn more! In addition to hydromorphone, Pfizer also has made Morphine Sulfate Injection, USP available to the U.S. As a result of CVM’s recent discussion with Pfizer, this product is now available in limited quantities for pain management in animals. The FDA had already given Pfizer permission to import Hydromorphone Hydrochloride Injection to help alleviate the ongoing opioid shortage in human medicine. to help alleviate a shortage of certain injectable opioids available to treat pain in animals, by facilitating the availability of a limited amount of product labeled for human use. The FDA announced that it has worked with Pfizer Inc. While the situation is improving, it will be towards the end of 2019, beginning of 2020 before the issues is resolved. Pfizer has released an updated statement about the shortage of sterile injectables. UPDATE 02.01.19: Opioid Shortage will Remain Throughout 2019
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |